Celldex Therapeutics
CLDX
#4527
Rank
โ‚ฌ1.69 B
Marketcap
25,43ย โ‚ฌ
Share price
-0.63%
Change (1 day)
0.91%
Change (1 year)

EPS for Celldex Therapeutics (CLDX)

EPS in 2023 (TTM): -2,27ย โ‚ฌ

According to Celldex Therapeutics's latest financial reports the company's current EPS (TTM) is -2,27ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -2,26ย โ‚ฌ a decrease over its 2021 EPS that were of -1,55ย โ‚ฌ.

EPS history for Celldex Therapeutics from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-2,27ย โ‚ฌ0.18%
2022-2,26ย โ‚ฌ45.73%
2021-1,55ย โ‚ฌ-23.36%
2020-2,03ย โ‚ฌ-41.05%
2019-3,44ย โ‚ฌ-76.95%
2018-14,92ย โ‚ฌ45.03%
2017-10,29ย โ‚ฌ-42.54%
2016-17,91ย โ‚ฌ-3.82%
2015-18,62ย โ‚ฌ-0.76%
2014-18,76ย โ‚ฌ29.41%
2013-14,50ย โ‚ฌ0%
2012-14,50ย โ‚ฌ-9.73%
2011-16,06ย โ‚ฌ1312.5%
2010-1,14ย โ‚ฌ-95.79%
2009-26,98ย โ‚ฌ-49.64%
2008-53,58ย โ‚ฌ-82.64%
2007-308,70ย โ‚ฌ-44.98%
2006-561,11ย โ‚ฌ1270.83%
2005-40,93ย โ‚ฌ33.33%
2004-30,70ย โ‚ฌ-10%
2003-34,11ย โ‚ฌ-16.67%
2002-40,93ย โ‚ฌ-38.46%
2001-66,51ย โ‚ฌ-4.88%
2000-69,93ย โ‚ฌ-79.37%
1999-339,01ย โ‚ฌ-87.2%
1998-2.648ย โ‚ฌ206.39%
1997-864,09ย โ‚ฌ13.02%
1996-764,58ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-3,80ย โ‚ฌ 67.08%๐Ÿ‡บ๐Ÿ‡ธ USA
-0,81ย โ‚ฌ-64.58%๐Ÿ‡บ๐Ÿ‡ธ USA
-11,45ย โ‚ฌ 403.33%๐Ÿ‡บ๐Ÿ‡ธ USA
13,41ย โ‚ฌ-689.58%๐Ÿ‡บ๐Ÿ‡ธ USA
1,76ย โ‚ฌ-177.50%๐Ÿ‡บ๐Ÿ‡ธ USA
3,32ย โ‚ฌ-245.86%๐Ÿ‡ฌ๐Ÿ‡ง UK
-0,54ย โ‚ฌ-76.25%๐Ÿ‡บ๐Ÿ‡ธ USA